On 30 October 2020 the Company Supervisory Board appointed Jeremy Launders as President of Bioton S.A.
Jeremy Launders is a leader with extensive experience in private and multinational companies within the biotech, pharma and medical devices sectors.
For the last 25 years he has worked in leadership roles in companies such as Baxter, Pfizer, Diasorin, and recently as VP of Operations and Supply Chain for Bimeda.
For the last 2 years Jeremy has led the implementation of strategic products to be launched on the market and ensured that Bimeda has achieved operational efficiency for these product lines.
You can find the President’s first statement below.
Bioton represents a huge opportunity to be a Market Leader in Diabetes Solutions. As you will be aware, the demand for products in this sector is growing significantly and patients are expecting innovative solutions to manage their condition.
Building on the solid foundations already laid down, my vision is the prioritisation of the supply of the existing product portfolio and the delivery of new products globally in order to satisfy our patients’ needs and for Bioton to become the primary choice ahead of our global competitors.
I will lead, guide and protect through this next phase with a strong emphasis on biotechnology solutions and delivery for our patients, while returning shareholder value.
As an innovative leader I anticipate I will make strong collaborations with our colleagues, customers and all stakeholders of the Bioton business.
It is with absolute pride that I take this opportunity and will pledge to be transparent, patient focused and results oriented while developing a diverse culture and workforce.
I would personally like to thank those leaders who have brought the company to where it is today. And I strongly anticipate that I will build on their results and safely take the company through the next phase of its journey.
Jeremy J Launders.